Navigation Links
Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Date:1/10/2014

GLENDALE, Wis., Jan. 10, 2014 /PRNewswire/ -- Crealta Pharmaceuticals LLC ("Crealta"), a new specialty pharmaceutical company, announced today the completion of the acquisition of substantially all of the assets of Savient Pharmaceuticals, Inc. ("Savient"). Crealta previously announced the winning of an auction for these assets, the signing of a definitive acquisition agreement with Savient, and the subsequent approval of the transaction by the U.S. Bankruptcy Court for the District of Delaware.

The key asset acquired by Crealta is KRYSTEXXA (pegloticase), a novel biologic product that was approved by the FDA in 2010. KRYSTEXXA is a PEGylated uric acid specific enzyme, or uricase, that has been shown to statistically significantly reduce uric acid levels for many patients with refractory chronic gout.

"We are tremendously excited to have completed the transaction, and more importantly, to ensure the continued availability of this critical product," commented Ed Fiorentino, Chairman and CEO of Crealta. "Crealta is committed to providing outstanding support and service to healthcare professionals and the patients that they serve with refractory chronic gout."

Crealta was established in August 2013 in partnership with GTCR, one of the nation's leading private equity firms.

KRYSTEXXA IMPORTANT SAFETY INFORMATION

The following information is provided in both the U.S. and European prescribing information.

KRYSTEXXA is not indicated for the treatment of asymptomatic hyperuricemia. KRYSTEXXA is indicated for adults who have tried or cannot take oral gout medications and still have high uric acid levels and signs and symptoms of gout. Patients who have a genetic condition known as G6PD deficiency should not use KRYSTEXXA.

Discontinue oral urate-lowering therapies before instituting KRYSTEXXA and do not institute oral urate-lowering the
'/>"/>

SOURCE Crealta Pharmaceuticals LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals
2. Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704
3. Novartis Pharmaceuticals Corporation stands behind medication adherence activities and reaffirms commitment to patient safety
4. Upcoming Conferences, Share Price Updates, and Leadership Changes - Research Report on Lilly, Allergan, Waters, Novavax, and Supernus Pharmaceuticals
5. Auxilium Pharmaceuticals, Inc. To Present At The J.P. Morgan 32nd Annual Healthcare Conference
6. Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics
8. Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
9. Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13
10. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
11. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Uroplasty, Inc. (NASDAQ: UPI ), a ... innovative proprietary products to treat voiding dysfunctions, today ... quarter ended June 30, 2014.  Global revenue ... grew 19% to $4.1 million, as compared to ... prior year.  Total revenue for the fiscal first ...
(Date:7/24/2014)... , July 24, 2014  IRIDEX Corporation (NASDAQ: ... release its second quarter 2014 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, July ... quarter and other business developments. Interested parties ...
(Date:7/24/2014)... IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has accepted  Damian ... Finio has accepted a senior level finance position at ... acceptance of his new position, Mr. Finio will be ... IGI Laboratories, Inc.  The effective date of his resignation ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... 21 Accuray Incorporated (Nasdaq: ARAY ), a ... plans to establish an America,s region thereby establishing regionalized ... , The formation of this new Americas region, ... and Japan, gives each region control of revenue and ...
... , WARSAW, Ind., Oct. 21 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending October 3, 2009 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:7/25/2014)... The Little Gym of Houston will ... July 27 at Discovery Green in downtown Houston. The ... Pearland, Friendswood, Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire ... “We’re thrilled to be attending and performing at the ... owns the Sugarland-Missouri City location. “We believe in the ...
(Date:7/25/2014)... July 25, 2014 AttorneyOne.com, a recognized authority ... information from the FDA on Ibuprofen and Oxcarbazepine Tablets ... one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, ... to mislabeled packaging. Oxcarbazepine is used for the treatment of ... , The reason for the recall is that Lot #142588, ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... July 25, 2014 On July ... Nuanced Media client and the nation’s number one ... employee handbooks, announced their partnership with TransAct Merchant ... a registered ISO/MSP of Chase Paymentech Solutions, LLC, ... processing industry. Companies that are members of TransAct’s ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Hastings and ... offering discount attorney’s fees with regard to personal injury ... provide a wide range of legal services for those ... negligence of another individual or corporation. Free initial consultation ... the validity of a potential personal injury claim ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3
... Enables Users to Upload Video Confessions/ Testimonials for ... for Peer-to-Peer Viewing, PHILADELPHIA and LONDON, Nov. ... (NYSE: TOC ; TSX: TOC) and,leading provider ... communities, today announced the launch of its new ...
... (Nasdaq: SPPI ) announced today that it will ... 2007, at 2:00 p.m.,Pacific, at the BIOCOM Investor Conference, ... California. Spectrum,s presentation will be held in Room,3 of ... of Spectrum,s presentation will be available at, http://www.spectrumpharm.com . ...
... MISSISSAUGA, ON, Oct. 31 /PRNewswire-FirstCall/ - DRAXIS Health Inc.,(TSX: ... Barkin today informed,the board of directors that he will ... Company effective December 31, 2007. Dr. Barkin joined ... fifteen years, he has been instrumental in guiding the ...
... Human Services Agency Secretary Kim Belshe indicated in,legislative ... Governor,s,plan to require all Californians to buy private ... digit insurance company premium increases.,The proposal does not ... and Consumer Rights., In response to questions ...
... Fla., Oct. 31 Cogon Systems, Inc. has ... by the U.S.,Army,s Telemedicine & Advanced Technology Research ... for hand held computer,use. The primary goal ... mobile,technology in an inpatient setting to deliver clinical ...
... Calif., Oct. 31 Always Best Care Senior,Services ... In-Home Care, Assisted Living Placement Service, and Personal,Response ... can now,rely on Always Best Care Senior Services ... relationship has been the foundation of our work ...
Cached Medicine News:Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:Spectrum Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 3Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 4Health News:Governor's Health Plan Hides the True Cost of a Mandatory Purchase Requirement, Testimony Shows 2Health News:U.S. Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 2Health News:Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area 2
Bones is a remarkable guide for the Medical Student, Nurse, Nurse Practitioner, Physician's Assistant or Physician to Bones....
The Urinary System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the urinary system....
... The perfect on-the-spot ... symptoms and disease. On ... office, on rounds, or ... reference provides instant access ...
The Nervous System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the nervous system....
Medicine Products: